Cytek Biosciences (CTKB) Operating Income (2020 - 2025)
Historic Operating Income for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$9.2 million.
- Cytek Biosciences' Operating Income fell 11638.42% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.8 million, marking a year-over-year decrease of 3450.48%. This contributed to the annual value of -$20.5 million for FY2024, which is 2629.56% up from last year.
- Per Cytek Biosciences' latest filing, its Operating Income stood at -$9.2 million for Q3 2025, which was down 11638.42% from -$10.6 million recorded in Q2 2025.
- Cytek Biosciences' 5-year Operating Income high stood at $3.8 million for Q2 2021, and its period low was -$15.0 million during Q1 2025.
- In the last 5 years, Cytek Biosciences' Operating Income had a median value of -$2.4 million in 2022 and averaged -$4.0 million.
- In the last 5 years, Cytek Biosciences' Operating Income crashed by 92435.47% in 2023 and then surged by 227956.2% in 2024.
- Quarter analysis of 5 years shows Cytek Biosciences' Operating Income stood at $1.3 million in 2021, then tumbled by 93.62% to $84000.0 in 2022, then plummeted by 263.1% to -$137000.0 in 2023, then surged by 2279.56% to $3.0 million in 2024, then crashed by 407.84% to -$9.2 million in 2025.
- Its last three reported values are -$9.2 million in Q3 2025, -$10.6 million for Q2 2025, and -$15.0 million during Q1 2025.